Quick Answer
Vera Therapeutics, Inc. reported Net Income of -$299.62 million for fiscal year 2025.
Vera Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$299.62M | -96.9% |
| 2024 | -$152.15M | -58.5% |
| 2023 | -$95.99M | -7.8% |
| 2022 | -$89.06M | -173.1% |
| 2021 | -$32.61M | +38.9% |
| 2020 | -$53.41M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$80.29M | -72.2% | -4.9% |
| June 30, 2025 | -$76.53M | -127.0% | -48.0% |
| March 31, 2025 | -$51.69M | -82.1% | -10.9% |
| September 30, 2024 | -$46.63M | -132.0% | -38.3% |
| June 30, 2024 | -$33.71M | -67.2% | -18.8% |
| March 31, 2024 | -$28.38M | +5.6% | -41.2% |
| September 30, 2023 | -$20.10M | +18.5% | +0.3% |
| June 30, 2023 | -$20.16M | -35.7% | +32.9% |
- Vera Therapeutics, Inc. showed a decrease of -96.9% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Vera Therapeutics, Inc.’s net income has declined by 460.9% (from -$53.41 million to -$299.62 million).
- The most recent figure is from Vera Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: